OA10258A - Oxathiolanes leur procédé de préparation et les compositions pharmaceutiques qui en referment - Google Patents

Oxathiolanes leur procédé de préparation et les compositions pharmaceutiques qui en referment Download PDF

Info

Publication number
OA10258A
OA10258A OA60770A OA60770A OA10258A OA 10258 A OA10258 A OA 10258A OA 60770 A OA60770 A OA 60770A OA 60770 A OA60770 A OA 60770A OA 10258 A OA10258 A OA 10258A
Authority
OA
OAPI
Prior art keywords
general formula
radical
compounds according
cis
formula
Prior art date
Application number
OA60770A
Other languages
English (en)
French (fr)
Inventor
Anne-Sophie Charvet-Faury
Michel Camplo
Jean-Louis Kraus
Original Assignee
Laphal Laboratoires Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laphal Laboratoires Sa filed Critical Laphal Laboratoires Sa
Publication of OA10258A publication Critical patent/OA10258A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA60770A 1994-05-24 1996-01-24 Oxathiolanes leur procédé de préparation et les compositions pharmaceutiques qui en referment OA10258A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9406262A FR2720397B1 (fr) 1994-05-24 1994-05-24 Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.

Publications (1)

Publication Number Publication Date
OA10258A true OA10258A (fr) 1997-10-07

Family

ID=9463449

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60770A OA10258A (fr) 1994-05-24 1996-01-24 Oxathiolanes leur procédé de préparation et les compositions pharmaceutiques qui en referment

Country Status (19)

Country Link
US (1) US5708000A (cs)
EP (1) EP0733053A1 (cs)
JP (1) JPH09502453A (cs)
KR (1) KR100242891B1 (cs)
CN (1) CN1080264C (cs)
AP (1) AP612A (cs)
AU (1) AU688052B2 (cs)
BR (1) BR9506244A (cs)
CA (1) CA2167930A1 (cs)
CZ (1) CZ21996A3 (cs)
FI (1) FI960316A7 (cs)
FR (1) FR2720397B1 (cs)
HU (1) HU219299B (cs)
NO (1) NO306299B1 (cs)
NZ (1) NZ287478A (cs)
OA (1) OA10258A (cs)
PL (1) PL181713B1 (cs)
RU (1) RU2142462C1 (cs)
WO (1) WO1995032200A1 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2720397B1 (fr) * 1994-05-24 1996-08-23 Laphal Laboratoires Sa Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.
IT1290447B1 (it) 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
US8354427B2 (en) * 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
LT2502911T (lt) 2004-06-24 2017-09-11 Vertex Pharmaceuticals Incorporated Atp surišančios kasetės transporterių moduliatoriai
CA2634113A1 (en) * 2005-12-24 2007-07-05 Vertex Pharmaceuticals Incorporated Quinolin- 4 - one derivatives as modulators of abc transporters
WO2007079139A2 (en) 2005-12-28 2007-07-12 Vertex Pharmaceuticals, Inc. Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
UY30118A1 (es) * 2006-01-31 2007-06-29 Tanabe Seiyaku Co Compueto amina trisustituido
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
SI2408750T1 (sl) 2009-03-20 2015-11-30 Vertex Pharmaceuticals Incorporated Postopek za izdelavo modulatorjev cistično-fibroznega transmembranskega regulatorja prevodnosti
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
EP2819670A1 (en) 2012-02-27 2015-01-07 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administration thereof
KR20170063954A (ko) 2014-10-07 2017-06-08 버텍스 파마슈티칼스 인코포레이티드 낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
DK0560794T3 (da) * 1990-11-13 1996-12-23 Iaf Biochem Int Substituerede 1,3-oxathiolaner med antivirale egenskaber
IL100965A (en) * 1991-02-22 1999-12-31 Univ Emory 2-Hydroxymethyl-5-(5-fluorocytosin-l-yl)-1,3-oxathiolane its resolution and pharmaceutical compositions containing it
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
FR2720397B1 (fr) * 1994-05-24 1996-08-23 Laphal Laboratoires Sa Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.

Also Published As

Publication number Publication date
CA2167930A1 (fr) 1995-11-30
WO1995032200A1 (fr) 1995-11-30
FR2720397B1 (fr) 1996-08-23
HU219299B (en) 2001-03-28
AP9600784A0 (en) 1996-04-30
FI960316A0 (fi) 1996-01-23
NO306299B1 (no) 1999-10-18
CN1080264C (zh) 2002-03-06
HUT75112A (en) 1997-04-28
KR960703903A (ko) 1996-08-31
AU2620995A (en) 1995-12-18
FR2720397A1 (fr) 1995-12-01
FI960316L (fi) 1996-03-22
CZ21996A3 (en) 1996-05-15
US5708000A (en) 1998-01-13
KR100242891B1 (ko) 2000-03-02
RU2142462C1 (ru) 1999-12-10
FI960316A7 (fi) 1996-03-22
PL181713B1 (en) 2001-09-28
JPH09502453A (ja) 1997-03-11
AU688052B2 (en) 1998-03-05
EP0733053A1 (fr) 1996-09-25
NZ287478A (en) 1997-09-22
NO960272L (no) 1996-01-23
AP612A (en) 1997-09-05
CN1130906A (zh) 1996-09-11
BR9506244A (pt) 1997-08-12
NO960272D0 (no) 1996-01-23
PL312693A1 (en) 1996-05-13

Similar Documents

Publication Publication Date Title
KR0172590B1 (ko) 2-히드록시메틸-5-(5-플루오로시토신-1-일)-1,3-옥사티올란의 항비루스 활성 및 그것의 분해방법
RU2126405C1 (ru) (-)-4-амино-5-фтор-1-(2-гидроксиметил-1,3-оксатиолан-5-ил)-(1h)-пиримидин- 2-он, смесь его энантиомеров, способы их получения, способ лечения
JP3421335B2 (ja) 鏡像異性的に純粋なβ−Ｄ−（−）−ジオキソラン−ヌクレオシド
CA2882201C (en) Tenofovir prodrug and pharmaceutical uses thereof
CZ309696A3 (en) Diastereoselective process for preparing nucleoside analogs
OA10258A (fr) Oxathiolanes leur procédé de préparation et les compositions pharmaceutiques qui en referment
JPH08501086A (ja) エナンチオマー的に純粋なβ‐Ｄ‐ジオキソラン−ヌクレオシド
JPH09512526A (ja) 抗ウイルス性を有する置換１，３−オキサチオラン
CN113929724A (zh) 一种核苷类化合物及其药物组合物和用途
JPH07504673A (ja) 抗ウイルス活性を有するインドール誘導体
CA2436958A1 (fr) Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation
CZ293942B6 (cs) Způsob zvýšení výtěžku jednoho z enanciomerů alkoholů
FR2528311A1 (fr) Compositions pharmaceutiques a base de xylosides et lyxosides de bases puriques et pyrimidiques
EP0843663B9 (fr) 4-aryl-thio-pyridin-2(1h)-ones, medicaments les contenant et leurs utilisations dans le traitement de maladies liees aux vih
JPH0692986A (ja) 置換ヌクレオシド誘導体、その製造法およびそれを含む医薬組成物
Camplo et al. Synthesis and antiviral activity of N-4′-dihydropyridinyl and dihydroquinolinylcarbonyl-2-hydroxymethyl-5-[cytosin-1′-yl]-1, 3-oxathiolane derivatives against human immunodeficiency virus and duck hepatitis B virus
EP0121635A1 (fr) 3',5'-Diarabinosides, leur préparation et leur application en thérapeutique
RU2235724C2 (ru) Способы разделения смеси энантиомеров
WO1997034891A1 (fr) 1,3-thiazolidin-4-ones et 1,3-thiazolidines substituees, procede d'obtention de ces composes et leurs utilisations comme medicaments
PL171150B1 (pl) Sposób rozdzielania racemicznej mieszaniny enancjomerów nukleozydu PL PL
MC1436A1 (fr) Composes de nucleosides a structure cyclique ouverte
CA2033798A1 (fr) Derives de la thymidine, leur preparation et les compositions qui les contiennent